1. Home
  2. GREE vs CTXR Comparison

GREE vs CTXR Comparison

Compare GREE & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenidge Generation Holdings Inc.

GREE

Greenidge Generation Holdings Inc.

N/A

Current Price

$1.60

Market Cap

20.4M

Sector

Finance

ML Signal

N/A

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

N/A

Current Price

$0.84

Market Cap

16.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GREE
CTXR
Founded
1937
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
16.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
GREE
CTXR
Price
$1.60
$0.84
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
107.6K
585.2K
Earning Date
01-01-0001
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.63
52 Week High
$2.42
$2.38

Technical Indicators

Market Signals
Indicator
GREE
CTXR
Relative Strength Index (RSI) 63.90 55.02
Support Level $1.13 $0.66
Resistance Level $1.71 $0.97
Average True Range (ATR) 0.12 0.07
MACD 0.04 0.02
Stochastic Oscillator 100.00 58.09

Price Performance

Historical Comparison
GREE
CTXR

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: